| Cameron Ryan, MD | |
|
1 Jarrett White Rd, Tripler Army Medical Center, HI 96859-5001 | |
| (808) 433-1640 | |
| (808) 433-3973 |
| Full Name | Cameron Ryan |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 1 Jarrett White Rd, Tripler Army Medical Center, Hawaii |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184085326 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 30367 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Cameron Ryan, MD 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859-5001 Ph: (808) 433-1640 | Cameron Ryan, MD 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859-5001 Ph: (808) 433-1640 |
News Archive
A large-scale analysis of patients whose myelodysplastic syndrome is related to earlier cancer treatment overturns the notion that all of them have a poor prognosis, researchers from The University of Texas MD Anderson Cancer Center report at the 53rd Annual Meeting of the American Society of Hematology.
An alarming report from patient online websites on persistent side effects of antidepressant drugs has been published in one of the last issue of Psychotherapy and Psychosomatics by investigators from the University of Bologna and North America.
Cancer-related effects and the treatment itself can have a significant psychosocial impact on cancer survivors. A recent study (STEP study) that assessed over 1800 cancer survivors across ten countries in Asia Pacific was presented at the ESMO Asia Congress today.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a second Phase 1B clinical safety and pilot efficacy study with PMX-60056, a small synthetic molecule designed to reverse heparin and low molecular weight heparin anticoagulants.
A study conducted by researchers at The University of Texas MD Anderson Cancer Center demonstrated acceptable toxicity and anti-tumor activity in patients with four types of advanced, hard-to-treat rare cancers.
› Verified 3 days ago
Mr. Adrian Scott Worthen, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, Tripler Army Medical Center, HI 96859 Phone: 808-433-4049 | |
Dr. James Nguyen, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 808-433-6527 | |
Dr. Pedro Acfalle Manibusan Jr., D.O. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 808-433-5055 | |
Robert Leimbach, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 088-433-6933 Fax: 808-433-3097 | |
Jenny Ryan, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 808-433-9363 | |
Dr. Franklin Whitney Goldwire, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 808-433-1077 | |
Dr. Alexander James Peckham Iv, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 808-433-6341 |